{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T09:48:46Z","timestamp":1770976126024,"version":"3.50.1"},"reference-count":71,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pulmonary Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1016\/j.pupt.2007.12.004","type":"journal-article","created":{"date-parts":[[2008,2,19]],"date-time":"2008-02-19T20:19:33Z","timestamp":1203452373000},"page":"540-550","source":"Crossref","is-referenced-by-count":35,"title":["The impact of inhaled corticosteroid and long-acting \u03b2-agonist combination therapy on outcomes in COPD"],"prefix":"10.1016","volume":"21","author":[{"given":"Nicola A.","family":"Hanania","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pupt.2007.12.004_bib1","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0140-6736(04)16855-4","article-title":"Burden and clinical features of chronic obstructive pulmonary disease (COPD)","volume":"364","author":"Pauwels","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.pupt.2007.12.004_bib2","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1183\/09031936.06.00025805","article-title":"Chronic obstructive pulmonary disease: current burden and future projections","volume":"27","author":"Lopez","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2007.12.004_bib3","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1183\/09031936.06.00024505","article-title":"Epidemiology and costs of chronic obstructive pulmonary disease","volume":"27","author":"Chapman","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2007.12.004_bib4","unstructured":"World Health Organization. The World Health Report 2004: Changing History. Available from; \u3008http:\/\/www.who.int\/whr\/2004\/en\/\u3009 [accessed 16.11.07]."},{"key":"10.1016\/j.pupt.2007.12.004_bib5","doi-asserted-by":"crossref","first-page":"14981504","DOI":"10.1016\/S0140-6736(96)07492-2","article-title":"Alternative projections of mortality and disability by cause 1990\u20132020: Global Burden of Disease Study","volume":"349","author":"Murray","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.pupt.2007.12.004_bib6","unstructured":"World Health Organization. Chronic obstructive pulmonary disease (COPD) data fact sheet no. 315. Available from; \u3008http:\/\/www.who.int\/mediacentre\/factsheets\/fs315\/en\/index.html\u3009 [accessed 16.11.07]."},{"key":"10.1016\/j.pupt.2007.12.004_bib7","unstructured":"US Department of Health and Human Services, National Institutes of Health. Chronic obstructive pulmonary disease (COPD) data fact sheet. Available from; \u3008http:\/\/www.nhlbi.nih.gov\/health\/public\/lung\/other\/copd_fact.pdf\u3009 [accessed 16.11.07]."},{"key":"10.1016\/j.pupt.2007.12.004_bib8","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(04)16900-6","article-title":"Pathophysiology of airflow limitation in chronic obstructive pulmonary disease","volume":"364","author":"Hogg","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.pupt.2007.12.004_bib9","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1056\/NEJMoa032158","article-title":"The nature of small-airway obstruction in chronic obstructive pulmonary disease","volume":"350","author":"Hogg","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pupt.2007.12.004_bib10","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1164\/rccm.2111084","article-title":"Airway inflammation in severe chronic obstructive pulmonary disease: relationship with lung function and radiologic emphysema","volume":"166","author":"Turato","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2007.12.004_bib11","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1164\/ajrccm.155.2.9032192","article-title":"Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD","volume":"155","author":"Keatings","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2007.12.004_bib12","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.rmed.2004.11.006","article-title":"COPD, a multicomponent disease: implications for management","volume":"99","author":"Agusti","year":"2005","journal-title":"Respir Med"},{"key":"10.1016\/j.pupt.2007.12.004_bib13","doi-asserted-by":"crossref","first-page":"127S","DOI":"10.1378\/chest.121.5_suppl.127S","article-title":"Systemic effects in COPD","volume":"121","author":"Wouters","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2007.12.004_bib14","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1183\/09031936.03.00405703","article-title":"Systemic effects of chronic obstructive pulmonary disease","volume":"21","author":"Agusti","year":"2003","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2007.12.004_bib15","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1136\/thx.2003.019588","article-title":"Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis","volume":"59","author":"Gan","year":"2004","journal-title":"Thorax"},{"key":"10.1016\/j.pupt.2007.12.004_bib16","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1183\/09031936.00133805","article-title":"Mortality in COPD: role of comorbidities","volume":"28","author":"Sin","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2007.12.004_bib17","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1183\/09031936.05.00010604","article-title":"Are patients with COPD psychologically distressed?","volume":"26","author":"Wagena","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2007.12.004_bib18","unstructured":"Global Initiative for Chronic Obstructive Lung Disease. Updated 2006. Available from; \u3008www.goldcopd.com\u3009 [accessed 16.11.07]."},{"key":"10.1016\/j.pupt.2007.12.004_bib19","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1001\/jama.272.19.1497","article-title":"Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study","volume":"272","author":"Anthonisen","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.pupt.2007.12.004_bib20","doi-asserted-by":"crossref","first-page":"233","DOI":"10.7326\/0003-4819-142-4-200502150-00005","article-title":"Lung Health Study Research Group. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial","volume":"142","author":"Anthonisen","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.pupt.2007.12.004_bib21","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1183\/09031936.04.00014304","article-title":"Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS\/ERS position paper","volume":"23","author":"Celli","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2007.12.004_bib22","first-page":"262","article-title":"Interventions to facilitate smoking cessation","volume":"74","author":"Okuyemi","year":"2006","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.pupt.2007.12.004_bib23","doi-asserted-by":"crossref","first-page":"391","DOI":"10.7326\/0003-4819-93-3-391","article-title":"Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial","volume":"93","year":"1980","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.pupt.2007.12.004_bib24","first-page":"681","article-title":"Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema","volume":"1","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.pupt.2007.12.004_bib25","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1055\/s-2007-1021332","article-title":"Surgical therapy for chronic obstructive pulmonary disease: conventional bullectomy and lung volume reduction surgery in the absence of giant bullae","volume":"20","author":"Martinez","year":"1999","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2007.12.004_bib26","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1164\/ajrccm.158.1.15812","article-title":"International guidelines for the selection of lung transplant candidates","volume":"158","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2007.12.004_bib27","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1136\/bmj.320.7245.1297","article-title":"Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial","volume":"320","author":"Burge","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.pupt.2007.12.004_bib28","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1056\/NEJM199906243402503","article-title":"Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease","volume":"340","author":"Pauwels","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pupt.2007.12.004_bib29","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1056\/NEJM200012283432601","article-title":"Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease","volume":"343","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pupt.2007.12.004_bib30","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1136\/thorax.58.11.937","article-title":"Inhaled corticosteroids reduce the progression of airflow limitation in chronic obstructive pulmonary disease: a meta-analysis","volume":"58","author":"Sutherland","year":"2003","journal-title":"Thorax"},{"key":"10.1016\/j.pupt.2007.12.004_bib31","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1378\/chest.06-1696","article-title":"A poled analysis of FEV1 decline in COPD patients randomized to inhaled corticosteroids or placebo","volume":"131","author":"Soriano","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2007.12.004_bib32","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0140-6736(03)12459-2","article-title":"Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial","volume":"361","author":"Calverley","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.pupt.2007.12.004_bib33","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1164\/rccm.2112055","article-title":"Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary disease","volume":"166","author":"Mahler","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2007.12.004_bib34","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1378\/chest.124.3.834","article-title":"The efficacy and safety of fluticasone propionate (250\u03bcg)\/salmeterol (250\u03bcg) combined in the Diskus inhaler for the treatment of COPD","volume":"124","author":"Hanania","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2007.12.004_bib35","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1164\/rccm.200602-244OC","article-title":"Impact of salmeterol\/fluticasone propionate versus salmeterol on exacerbations in severe COPD","volume":"175","author":"Kardos","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2007.12.004_bib36","first-page":"A110","article-title":"Number needed to treat (NNT) to reduce exacerbations in severe COPD comparing salmeterol\/fluticasone propionate (SFC) with salmeterol (SAL) treatment","volume":"3","author":"Vogelmeier","year":"2006","journal-title":"Proc Am Thorac Soc"},{"issue":"Suppl. 50","key":"10.1016\/j.pupt.2007.12.004_bib37","first-page":"34s","article-title":"The TORCH (TOwards a Revolution in COPD Health) study: salmeterol\/fluticasone propionate (SFC) improves health status, reduces exacerbations and improves lung function over three years (abstract)","volume":"28","author":"Celli","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2007.12.004_bib38","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1183\/09031936.03.00031402","article-title":"Efficacy and safety of budesonide\/formoterol in the management of chronic obstructive pulmonary disease","volume":"21","author":"Szafranski","year":"2003","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2007.12.004_bib39","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1183\/09031936.03.00027003","article-title":"Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease","volume":"22","author":"Calverley","year":"2003","journal-title":"Eur Respir J"},{"issue":"Issue 3","key":"10.1016\/j.pupt.2007.12.004_bib40","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003794.pub2","article-title":"Combined corticosteroid and long acting beta-agonist in one inhaler for chronic obstructive pulmonary disease","author":"Nannini","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.pupt.2007.12.004_bib41","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ejphar.2005.12.049","article-title":"Corticosteroids and adrenoceptor agonists: the compliments for combination therapy in chronic airways diseases","volume":"533","author":"Sin","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pupt.2007.12.004_bib42","doi-asserted-by":"crossref","first-page":"S261","DOI":"10.1067\/mai.2002.129705","article-title":"Molecular interactions between glucocorticoids and long-acting beta2-agonists","volume":"110","author":"Adcock","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.pupt.2007.12.004_bib43","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0140-6736(02)11319-5","article-title":"Interaction between glucocorticoids and beta2 agonists on bronchial airway smooth muscle cells through synchronised cellular signalling","volume":"360","author":"Roth","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.pupt.2007.12.004_bib44","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1165\/rcmb.2005-0385OC","article-title":"Combination therapy: synergistic suppression of virus induced chemokines in airway epithelial cells","volume":"34","author":"Edwards","year":"2006","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.pupt.2007.12.004_bib45","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1164\/rccm.200508-1321OC","article-title":"Anti-inflammatory effects of salmeterol\/fluticasone propionate in chronic obstructive lung disease","volume":"173","author":"Barnes","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2007.12.004_bib46","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1136\/thx.2006.071068","article-title":"Effect of salmeterol\/fluticasone propionate on airway inflammation in COPD: a randomized controlled trial","volume":"63","author":"Bourbeau","year":"2007","journal-title":"Thorax"},{"key":"10.1016\/j.pupt.2007.12.004_bib47","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1136\/thx.2004.033266","article-title":"Addition of salmeterol to existing treatment in patients with COPD: a 12 month study","volume":"61","author":"Stockley","year":"2006","journal-title":"Thorax"},{"key":"10.1016\/j.pupt.2007.12.004_bib48","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1136\/thx.2004.034280","article-title":"Withdrawal of fluticasone propionate from combined salmeterol\/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial","volume":"60","author":"Wouters","year":"2005","journal-title":"Thorax"},{"key":"10.1016\/j.pupt.2007.12.004_bib49","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1378\/chest.130.3.647","article-title":"Effect of fluticasone propionate\/salmeterol on lung hyperinflation and exercise endurance in COPD","volume":"130","author":"O\u2019Donnell","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2007.12.004_bib50","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1056\/NEJMoa063070","article-title":"Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease","volume":"356","author":"Calverley","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pupt.2007.12.004_bib51","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1136\/thorax.57.10.847","article-title":"Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease","volume":"57","author":"Donaldson","year":"2002","journal-title":"Thorax"},{"key":"10.1016\/j.pupt.2007.12.004_bib52","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1164\/ajrccm.157.5.9709032","article-title":"Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease","volume":"157","author":"Seemungal","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2007.12.004_bib53","doi-asserted-by":"crossref","first-page":"579","DOI":"10.2165\/00003495-200565050-00001","article-title":"Inhaled corticosteroids in chronic obstructive pulmonary disease: is there a clinical benefit?","volume":"65","author":"Man","year":"2005","journal-title":"Drugs"},{"key":"10.1016\/j.pupt.2007.12.004_bib54","first-page":"CD001104","article-title":"Long-acting beta2-agonists for poorly reversible chronic obstructive pulmonary disease","volume":"3","author":"Appleton","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"issue":"10 Suppl. 1","key":"10.1016\/j.pupt.2007.12.004_bib55","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.amjmed.2006.08.006","article-title":"The impact of severe exacerbations on quality of life and the clinical course of chronic obstructive pulmonary disease","volume":"119","author":"Niewoehner","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.pupt.2007.12.004_bib56","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1081\/COPD-200050513","article-title":"St. George's Respiratory Questionnaire: MCID","volume":"2","author":"Jones","year":"2005","journal-title":"COPD"},{"issue":"10 Suppl. 1","key":"10.1016\/j.pupt.2007.12.004_bib57","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.amjmed.2006.08.005","article-title":"Functional status and quality of life in chronic obstructive pulmonary disease","volume":"119","author":"Reardon","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.pupt.2007.12.004_bib58","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0002-9343(02)01143-9","article-title":"The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review of randomized placebo-controlled trials","volume":"113","author":"Alsaeedi","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.pupt.2007.12.004_bib59","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1136\/thx.2005.045385","article-title":"Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease","volume":"60","author":"Sin","year":"2005","journal-title":"Thorax"},{"key":"10.1016\/j.pupt.2007.12.004_bib60","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1164\/ajrccm.164.4.2009033","article-title":"Inhaled corticosteroids and the risk of mortality and readmission in elderly patients with chronic obstructive pulmonary disease","volume":"164","author":"Sin","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2007.12.004_bib61","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1183\/09031936.03.00040803","article-title":"Inhaled corticosteroids and survival in chronic obstructive pulmonary disease: does the dose matter?","volume":"21","author":"Sin","year":"2003","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2007.12.004_bib62","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1183\/09031936.02.00301302","article-title":"Survival in COPD patients after regular use of fluticasone propionate and salmeterol in general practice","volume":"20","author":"Soriano","year":"2002","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2007.12.004_bib63","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/BF03256640","article-title":"Inhaled corticosteroids with\/without long-acting beta-agonists reduce the risk of rehospitalization and death in COPD patients","volume":"2","author":"Soriano","year":"2003","journal-title":"Am J Respir Med"},{"key":"10.1016\/j.pupt.2007.12.004_bib64","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.rmed.2005.02.018","article-title":"Inhaled corticosteroids are more effective in COPD patients when used with LABA than with SABA","volume":"99","author":"Kiri","year":"2005","journal-title":"Respir Med"},{"key":"10.1016\/j.pupt.2007.12.004_bib65","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.rmed.2005.08.006","article-title":"Survival of COPD patients using inhaled corticosteroids and long-acting beta agonists","volume":"100","author":"Mapel","year":"2006","journal-title":"Respir Med"},{"key":"10.1016\/j.pupt.2007.12.004_bib66","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0149-2918(05)00052-4","article-title":"A comparison of the risk of hospitalizations due to chronic obstructive pulmonary disease in medicaid patients with various medication regimens, including ipratropium, inhaled corticosteroids, salmeterol, or their combination","volume":"27","author":"Rascati","year":"2005","journal-title":"Clin Ther"},{"key":"10.1016\/j.pupt.2007.12.004_bib67","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1164\/rccm.200210-1231OC","article-title":"Effectiveness of inhaled corticosteroids in chronic obstructive pulmonary disease: immortal time bias in observational studies","volume":"168","author":"Suissa","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2007.12.004_bib68","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1164\/rccm.200301-019OC","article-title":"Inhaled corticosteroids in chronic obstructive pulmonary disease and risk of death and hospitalization: time-dependent analysis","volume":"168","author":"Fan","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2007.12.004_bib69","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1164\/rccm.200502-210OC","article-title":"Inhaled corticosteroids in chronic obstructive pulmonary disease: results from two observational designs free of immortal time bias","volume":"172","author":"Kiri","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2007.12.004_bib70","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1001\/archinte.164.13.1427","article-title":"Effectiveness of statin therapy in adults with coronary heart disease","volume":"164","author":"Wilt","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.pupt.2007.12.004_bib71","first-page":"A110","article-title":"Survival of COPD patients using the Advair Diskus, inhaled corticosteroids and salmeterol individually, inhaled corticosteroids alone, or short acting bronchodilators alone","volume":"3","author":"Mapel","year":"2006","journal-title":"Proc Am Thorac Soc"}],"container-title":["Pulmonary Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553908000035?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553908000035?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,31]],"date-time":"2018-12-31T17:25:52Z","timestamp":1546277152000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094553908000035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":71,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S1094553908000035"],"URL":"https:\/\/doi.org\/10.1016\/j.pupt.2007.12.004","relation":{},"ISSN":["1094-5539"],"issn-type":[{"value":"1094-5539","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}